Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
McKesson
Fish and Richardson
Queensland Health
QuintilesIMS
UBS
US Army
Harvard Business School
Johnson and Johnson

Generated: June 19, 2018

DrugPatentWatch Database Preview

ZINECARD Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Zinecard patents expire, and what generic alternatives are available?

Zinecard is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in ZINECARD is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
Drug patent expirations by year for ZINECARD
Pharmacology for ZINECARD
Medical Subject Heading (MeSH) Categories for ZINECARD
Synonyms for ZINECARD
(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione
(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane
(+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane
(+)-1,5-dioxopiperazin-1-yl)propane
(+)-dexrazoxane
(S)-(+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane
(S)-(+)-1,5-dioxopiperazin-1-yl)propane
(S)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane
(S)-4,4-(Propane-1,2-diyl)bis(piperazine-2,6-dione)
(S)-4,4'-(1-METHYL-1,2-ETHANEDIYL)BIS-2,6-PIPERAZINEDIONE
(S)-4,4'-(Propane-1,2-diyl)-bis(piperazine-2,6-dione)
(S)-4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione)
048L81261F
2, 4,4'-propylenedi-, (+)-
2,4,4'-(1-methyl-1,2-ethanediyl)bis-, (S)-
2,4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)-
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)- (9CI)
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)-(9CI)
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (S)-
2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-
2,6-Piperazinedione, 4,4'-propylenedi-, (+)-
24584-09-6
4-[(2S)-1-(3,5-dioxopiperazin-1-yl)propan-2-yl]piperazine-2,6-dione
4-[(2S)-2-(3,5-dioxo-1-piperazinyl)propyl]piperazine-2,6-dione
4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione
4-[(2S)-2-[3,5-bis(oxidanylidene)piperazin-1-yl]propyl]piperazine-2,6-dione
4,?4'-?[(1S)-?1-?METHYL-?1,?2-?ETHANEDIYL]BIS-?2,?6-?PIPERAZINEDIONE
4,4'-(2S)-propane-1,2-diyldipiperazine-2,6-dione
4,4'-[(2S)-1,2-Propanediyl]di(2,6-piperazinedione)
584D096
6-hydroxy-4-[(2S)-2-(5-hydroxy-3-oxo-1,2,3,6-tetrahydropyrazin-1-yl)propyl]-2,3,4,5-tetrahydropyrazin-2-one
A817380
AB0011515
AB01273932_03
AB01273932-01
AB01273932-02
AC1L2G28
AC1Q6LVI
ADR 529
ADR-529
AJ-79327
AK-72797
AKOS015896392
AN-14921
ANW-44923
API0006306
AX8123889
BIDD:GT0068
BR-72797
BRD-K07265709-003-01-5
BRN 5759131
C-23732
C11H16N4O4
Cardioxane
Cardioxane (TN)
CAS-24584-09-6
CC-26376
CCRIS 9394
CHEBI:50223
CHEMBL1738
CS-2769
CTK8B4408
D03730
D07XVN
D0X3ST
D4227
DB00380
Desrazoxane
Dexrazone
Dexrazoxan
Dexrazoxane
Dexrazoxane (JAN/USAN/INN)
Dexrazoxane (TN)
Dexrazoxane (USAN/INN)
Dexrazoxane [USAN:BAN:INN]
Dexrazoxane [USAN:INN:BAN]
Dexrazoxane HCl (ICRF-187, ADR-529)
Dexrazoxane, >=95% (HPLC)
Dexrazoxane, analytical reference material
Dexrazoxano
Dexrazoxano [INN-Spanish]
Dexrazoxanum
Dexrazoxanum [INN-Latin]
Dextrorazoxane
DR000834
DS-1394
DSSTox_CID_20647
DSSTox_GSID_40647
DSSTox_RID_79520
DTXSID3040647
dyzoxane
EBD45155
Eucardion
FT-0653845
GTPL7330
HE110785
HSDB 7319
HY-B0581
I06-1989
ICRF 187
ICRF 187 hydrochloride
ICRF-187
J-015579
J-520219
J90038
KB-211519
KS-00000G0G
LS-111911
MFCD00866449
MLS006010158
MolPort-006-167-534
MP-0159
NCGC00164737-01
NCGC00263544-01
NCGC00263544-02
NCI60_001367
NSC 169780
NSC-169780
NSC169780
Razoxana [INN-Spanish]
Razoxane, (S)-Isomer
Razoxanum [INN-Latin]
RP29555
Savene
SCHEMBL18400
SMR002529680
Soluble ICRF (L-isosomer)
SR-01000883995
SR-01000883995-5
ST24026597
TopoTect
Totect
Totect (TN)
Totect, ICRF-187, Zinecard, Cardioxane, Dexrazoxane Hydrochloride
Tox21_112256
Tox21_112256_1
TR-011328
UNII-048L81261F
UNII-5AR83PR647 component BMKDZUISNHGIBY-ZETCQYMHSA-N
ZINC87515509
Zinecard (TN)

US Patents and Regulatory Information for ZINECARD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for ZINECARD

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Teva
Dow
QuintilesIMS
Julphar
Chubb
Cantor Fitzgerald
Daiichi Sankyo
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.